Value-Based Insurance Design Plans Linked to Higher Medication Adherence

Certain elements of value-based insurance design plans may lead to higher medication adherence, according to a study published in Health Affairs.

Advertisement

Researchers analyzed 76 VBID plans and their effect on medication adherence for more than 274,000 patients.

Studying VBID plan factors independently, researchers found the percentage of adherence increased for plans that provided more benefits (1.4 percent), restricted prescription benefits to mail orders (1.5 percent), had co-pay tiers (3.3 percent), provided wellness programs (2 percent) and targeted at-risk populations (1.7 percent).

Analyzing these factors simultaneously, except the presence of co-pay tiers, medication adherence increased even more, up to 4.8 percent.

Researchers suggest insurance plans in the future can be restructured to increase medication adherence and identify other benefit designs and quality improvements.

More Articles on Medication Adherence:

Improved Medication Adherence May Not Cut Costs, Study Finds
The Next Generation in Personalized Medicine and Medication Adherence Programs
Study: Patients Must Take Medication 80% of Time to Avoid Readmission

Advertisement

Next Up in Care Coordination

Advertisement

Comments are closed.